citalopram has been researched along with levodopa in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.67) | 18.2507 |
| 2000's | 7 (23.33) | 29.6817 |
| 2010's | 21 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| al-Tikriti, MS; Baldwin, RM; Laruelle, M; Malison, RT; Neumeyer, JL; Sybirska, EH; Wisniewski, G; Zea-Ponce, Y; Zimmermann, RC; Zoghbi, SS | 1 |
| Allikmets, L; Matto, V; Skrebuhhova, T | 1 |
| Bagheri, H; Montastruc, JL; Schmitt, L | 1 |
| Juckel, G; Klein, J; Kupsch, A; Lee, T; Morgenstern, R; Mundt, A; Petrus, D; von Rumohr, A; Winter, C | 1 |
| Barker, RA; Kuan, WL; Zhao, JW | 1 |
| Bioulac, B; De Deurwaerdère, P; Gross, C; Navailles, S | 1 |
| Chowdhury, R; Dayan, P; Dolan, RJ; Duzel, E; Guitart-Masip, M; Sharot, T | 1 |
| Bishop, C; Buchta, W; Dickinson, SO; Eissa, S; Eskow Jaunarajs, KL; George, JA; Goldenberg, AA; Mohamed, M | 1 |
| Chowdhury, R; Dolan, RJ; Guitart-Masip, M; Korn, CW; Sharot, T | 1 |
| Beierholm, U; Chowdhury, R; Dayan, P; Dolan, R; Düzel, E; Economides, M; Guitart-Masip, M | 1 |
| Bishop, C; Conti, MM; Dell'isola, R; Goldenberg, AA; Kampton, E; Katzman, AC; Lindenbach, D; Ostock, CY | 1 |
| Chowdhury, R; Dayan, P; Dolan, RJ; Duzel, E; Economides, M; Frank, MJ; Guitart-Masip, M; Huys, QJ | 1 |
| Acar, F; Acar, G; Karadag, F; Ugurlu, TT | 1 |
| Bishop, C; Conti, MM; Lindenbach, D; Ostock, CY; Palumbo, N; Vilceus, N | 1 |
| Bezard, E; Carta, M; Chuan, Q; Fidalgo, C; Ko, WK; Li, Q; Stancampiano, R; Tronci, E | 1 |
| Wise, J | 1 |
| Crockett, MJ; Dayan, P; Dolan, RJ; Frieband, C; Grosse-Rueskamp, JM; Kurth-Nelson, Z; Ousdal, OT; Siegel, JZ; Story, G | 1 |
| Buckholtz, JW; Dorfman, HM | 1 |
| Benazzouz, A; De Deurwaerdère, P; Delaville, C; Lagière, M; Marquis, L; Miguelez, C; Navailles, S; Ugedo, L | 1 |
| Arnulf, I; Miguel, R | 1 |
| Golebiowska, J; Rygula, R | 1 |
1 review(s) available for citalopram and levodopa
| Article | Year |
|---|---|
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease | 2003 |
4 trial(s) available for citalopram and levodopa
| Article | Year |
|---|---|
Action controls dopaminergic enhancement of reward representations.
Topics: Adolescent; Adult; Analysis of Variance; Citalopram; Corpus Striatum; Cues; Dopamine; Dopamine Agents; Double-Blind Method; Female; Fractals; Humans; Levodopa; Magnetic Resonance Imaging; Male; Psychomotor Performance; Punishment; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Substantia Nigra; Tegmentum Mesencephali; Time Factors; Young Adult | 2012 |
Dopamine modulates reward-related vigor.
Topics: Adolescent; Adult; Citalopram; Dopamine; Double-Blind Method; Female; Humans; Levodopa; Male; Motivation; Photic Stimulation; Psychomotor Performance; Reaction Time; Reward; Young Adult | 2013 |
Differential, but not opponent, effects of L -DOPA and citalopram on action learning with reward and punishment.
Topics: Adult; Avoidance Learning; Citalopram; Decision Making; Dopamine; Dopamine Agents; Double-Blind Method; Female; Humans; Learning; Levodopa; Male; Punishment; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Young Adult | 2014 |
Dissociable Effects of Serotonin and Dopamine on the Valuation of Harm in Moral Decision Making.
Topics: Adolescent; Adult; Aggression; Altruism; Citalopram; Decision Making; Dopamine; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Male; Morals; Selective Serotonin Reuptake Inhibitors; Serotonin; Young Adult | 2015 |
25 other study(ies) available for citalopram and levodopa
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
Topics: Animals; Brain; Brain Chemistry; Carrier Proteins; Chlorocebus aethiops; Citalopram; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Indans; Iodine Radioisotopes; Levodopa; Ligands; Maprotiline; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Papio; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon | 1993 |
The effect of antidepressants on rat aggressive behavior in the electric footshock and apomorphine-induced aggressiveness paradigms.
Topics: Aggression; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Citalopram; Desipramine; Dopamine Agents; Electroshock; Fluoxetine; Levodopa; Male; Pain Measurement; Rats; Rats, Wistar; Tryptophan | 1998 |
Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Functional Laterality; Helplessness, Learned; Levodopa; Male; Nerve Degeneration; Neurons; Oxidopamine; Rats; Rats, Wistar; Reaction Time; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2007 |
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
Topics: Adrenal Cortex Hormones; Amphetamine; Animals; Anxiety; Blotting, Western; Body Weight; Central Nervous System Stimulants; Citalopram; Dopamine Agents; Drinking; Dyskinesia, Drug-Induced; Image Processing, Computer-Assisted; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Stereotyped Behavior; Sympatholytics; Synaptic Transmission | 2008 |
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Animals; Antiparkinson Agents; Brain; Citalopram; Cobra Neurotoxin Proteins; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Extracellular Fluid; Levodopa; Male; Microdialysis; Oxidopamine; Parkinsonian Disorders; Presynaptic Terminals; Raphe Nuclei; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Sympatholytics; Synaptic Transmission | 2010 |
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskinesia, Drug-Induced; Fluoxetine; Levodopa; Male; Parkinsonian Disorders; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2012 |
How dopamine enhances an optimism bias in humans.
Topics: Affect; Attitude; Citalopram; Dopamine; Dopamine Agents; Female; Humans; Levodopa; Male; Selective Serotonin Reuptake Inhibitors; Young Adult | 2012 |
Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
Topics: Animals; Citalopram; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2014 |
Manic episode following deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a case report.
Topics: Antiparkinson Agents; Anxiety; Bipolar Disorder; Citalopram; Deep Brain Stimulation; Electrodes, Implanted; Female; Humans; Levodopa; Male; Medial Forebrain Bundle; Middle Aged; Parkinson Disease; Postoperative Complications; Selective Serotonin Reuptake Inhibitors; Subthalamic Nucleus | 2014 |
Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiparkinson Agents; Buspirone; Citalopram; Dyskinesia, Drug-Induced; Levodopa; Male; Parkinson Disease; Psychomotor Performance; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists | 2015 |
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Citalopram; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tyrosine 3-Monooxygenase | 2015 |
Common drugs can affect moral decision making, study finds.
Topics: Aggression; Citalopram; Dopamine Agents; Female; Humans; Levodopa; Male; Selective Serotonin Reuptake Inhibitors | 2015 |
Social Behavior: A Penny for Your Shocks.
Topics: Aggression; Citalopram; Dopamine Agents; Female; Humans; Levodopa; Male; Selective Serotonin Reuptake Inhibitors | 2015 |
L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
Topics: Action Potentials; Animals; Antiparkinson Agents; Cholestanols; Citalopram; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Hippocampus; Hydroxyindoleacetic Acid; Levodopa; Male; Organ Specificity; Parkinson Disease; Prefrontal Cortex; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Single-Cell Analysis; Synaptic Transmission | 2016 |
Phasic activity during non REM sleep.
Topics: Antiparkinson Agents; Citalopram; Humans; Levodopa; Male; Middle Aged; Muscle Tonus; Parkinson Disease; Polysomnography; REM Sleep Behavior Disorder; Selective Serotonin Reuptake Inhibitors; Sleep, REM | 2017 |
Effects of acute dopaminergic and serotonergic manipulations in the ACI paradigm depend on the basal valence of cognitive judgement bias in rats.
Topics: Animals; Citalopram; Cognition; Cues; Discrimination, Psychological; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Haloperidol; Judgment; Levodopa; Male; Optimism; Pessimism; Psychological Tests; Punishment; Rats, Sprague-Dawley; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin | 2017 |